Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Published Date: 24 Aug 2026

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Published Date: 24 Aug 2026

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

Published Date: 24 Aug 2026

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

Published Date: 24 Aug 2026

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

Published Date: 24 Aug 2026

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

Published Date: 24 Aug 2026

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Published Date: 24 Aug 2026

Improvements primarily driven by reduction in incidence of relapse

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Published Date: 24 Aug 2026

Half of procedures occurred in settings not supported by guidelines

FDA Approves First CELMoD Drug for Multiple Myeloma

Published Date: 24 Aug 2026

Iberdomide indicated as part of combination regimen for relapsed or refractory disease

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Published Date: 24 Aug 2026

Health news and commentary gathered by MedPage Today staff

Knowledge Hub

Oncology

Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data

Review of secure computational infrastructures for collaborative multicenter oncology research without centralizing patient data.

Oncology

Patient-Specific Tumor Resection Cavities With Biofabricated Reconstruction Materials

Comprehensive review of patient-specific biofabricated reconstruction materials for tumor resection cavities, focusing on clinical evidence and guideline-based practice.

Oncology

Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship

Comprehensive review on reasoning through new functional changes during long-term cancer survivorship, with evidence-based clinical insights.

Oncology

Clinical Pharmacology of Drug Exposure During Long-Term Cancer Survivorship

Comprehensive review of drug exposure and clinical pharmacology in long-term cancer survivors.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

FDA Approves First CELMoD Drug for Multiple Myeloma

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Knowledge Hub

Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data

Patient-Specific Tumor Resection Cavities With Biofabricated Reconstruction Materials

Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship

Clinical Pharmacology of Drug Exposure During Long-Term Cancer Survivorship

Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship

Emerging Therapies Using Tumor-Activated Prodrug Systems for Selective Cancer Cell Killing

Emerging Therapies Using Targeted Antibody–Drug Conjugates Against Previously Difficult Tumor Targets

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Study Questions How Prostate Cancer Focal Therapy Is Being Used

FDA Approves First CELMoD Drug for Multiple Myeloma

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Knowledge Hub

Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data

Patient-Specific Tumor Resection Cavities With Biofabricated Reconstruction Materials

Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship

Clinical Pharmacology of Drug Exposure During Long-Term Cancer Survivorship

Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship

Emerging Therapies Using Tumor-Activated Prodrug Systems for Selective Cancer Cell Killing

Emerging Therapies Using Targeted Antibody–Drug Conjugates Against Previously Difficult Tumor Targets

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views